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Innovation Drivers
in Microbiota R&D
A healthy and balanced microbial ecosystem in the intestinal tract 
can have a profound effect on health and well-being. In contrast, 
an imbalance in the microfl ora is associated with a large variety of 
syndromes and diseases. Modulating an imbalanced intestinal tract 
with ‘friendly’ bacteria is not new, as the health-promoting lactic acid 
bacteria in yoghurts and cheeses have a long history of use. Probiotic 
administration seems a promising method of modulating the aberrant 
intestinal tract. However, even though scientists have been working on 
probiotics for over a decade, there are still no products available with 
a health claim. Innovation in the fi eld of probiotics seems hampered; 
as a result patient needs in society may not be met. This thesis set out 
to assess innovation drivers in microbiota research & development in 
order to advance gut modulation. The potential properties, safety and 
effi cacy of probiotics as well as other barriers in the innovation process 
and future research directions are assessed. 
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